25.3 C
New York
Saturday, June 13, 2026

Tag: conversations

newssourceFORcompanyinformationcontent1marketreleases

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

Link’s “Hundred Flavours” Survey Decodes Hongkongers’ Taste DNA — Tuen Mun Residents Have the Sweetest Tooth, While Hongkongers “Can Eat Bitter” but Shy Away...

Mrs Mak and McDull Visit 24 Malls and Markets, Launching Exclusive Themed Premiums and Dining OffersThe "Hundred Flavours Survey" drew over 6,000 participants, uncovering...

ACC Co-Hosts 2026 Energy Imperatives Summit

WASHINGTON, June 10, 2026 /PRNewswire/ -- The American Conservation Coalition (ACC) co-hosted the second annual Energy Imperatives Summit, in partnership with American Affairs and...

Sierra Achieves FedRAMP High Certification Through Partnership with Knox Systems

Certification Equips U.S. Government Agencies to Transform Customer ExperienceSAN FRANCISCO and NEW YORK, June 10, 2026 /PRNewswire/ -- Sierra, the leading AI-powered customer experience platform,...

Bismarck Women’s Health Expert Hosts Free Community Event to Help Women Understand Heavy and Painful Periods

Featuring Dr. Rhonda Schafer-McLean, a board-certified OB/GYN with more than 15 years of experience caring for women throughout North Dakota 
Featuring Dr. Rhonda Schafer-McLean, a board-certified OB/GYN with more than 15 years of experience caring for women throughout North Dakota

Jet Linx Grounds Fleet to Challenge Private Aviation Safety Standards at 10th Annual Safety Summit

Confronting the Unthinkable and Pushing Beyond Industry StandardsOMAHA, Neb., June 10, 2026 /PRNewswire/ -- During a time when aviation safety is drawing increased attention...

Vallige Introduces Val — a Smart Companion to Support Families Living with Dementia

RENO, Nev., June 10, 2026 /PRNewswire/ -- Vallige, Inc., a service built to comfort people with dementia and reduce caregiver burden, today announced the...

ICIS expands polymer demand insight to help customers make better decisions across global plastics markets

LONDON, June 10, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, has secured exclusive access to the AMI Polymer Demand and Plastics Processors database,...

ICIS expands polymer demand insight to help customers make better decisions across global plastics markets

LONDON, June 10, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, has secured exclusive access to the AMI Polymer Demand and Plastics Processors database,...

SUNRATE Unveils Sunrate.AI, Defining Agentic Global Payments

SINGAPORE, June 10, 2026 /PRNewswire/ -- SUNRATE, the global payment and treasury management platform, today unveiled Sunrate.AI at SuperAI, defining 'Agentic Global Payments' —...

Medmovie Launches HxHeart.com, Bringing Its Trusted Cardiovascular Education Library to Any Browser — and Releases a New Video on the Hidden Risks of Coronary...

The same clinician-approved animations from the Hx Heart app are now available online at HxHeart.com — free, instantly, with no download required.BERKELEY, Calif., June...

EXPLORA JOURNEYS DEBUTS EXCLUSIVE FINE JEWELRY COLLECTION ‘MANDALA’ AT MONACO GRAND PRIX

Revealed during an exclusive gathering in Monte Carlo, key highlights of the milestone launch include:Exclusive Unveiling: The fine jewelry brand was officially unveiled on...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsConversations

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers